1. Orchard Therapeutics targets rare diseases

    Interviewee/Contributer: Mark Rothera

    Organisation: Orchard Therapeutics

    Read more

  2. The three waves of gene therapy

    Interviewee/Contributer: Frank Schnieders

    Organisation: Provecs Medical GmbH

    Read more

  3. Building the next generation of gene transfer vectors

    Interviewee/Contributer: Michael L Roberts

    Organisation: Synpromics Ltd

    Read more

  4. 2017 Oncology Review: Global oncology drug approvals accelerate

    Interviewee/Contributer: Bruno Pagliara

    Organisation: On-kòs Pharma Consulting

    Read more

  5. 2017 stock market review: Biotechs buoyed by share issues

    Interviewee/Contributer: William Ellington

    Organisation: MedNous

    Read more

  6. Europe's biotech entrepreneurs

    Interviewee/Contributer: Victoria English

    Organisation: MedNous

    Read more

  7. The case for value-based pricing

    Interviewee/Contributer: Tara Raveendran

    Organisation: Shore Capital

    Read more

  8. Bill Gates backs Alzheimer's disease research

    Interviewee/Contributer: Jean-Claude Muller

    Organisation: MedNous Editorial Board

    Read more

  9. The rise of single-arm studies in oncology

    Interviewee/Contributer: Bruno Pagliara

    Organisation: On-kòs Pharma Consulting

    Read more

  10. Priorities of the new Novartis CEO

    Interviewee/Contributer: Robin Davison

    Organisation: New Science Global Healthcare Fund

    Read more